Pressure ulcers in the pediatric patient

Kathryn Q Bernabe1

  • 1St Louis Children's Hospital, Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA. bernabek@wudosis.wustl.edu

Insights

Pediatric pressure ulcers are a preventable issue in hospitals. Increased awareness and timely assessments are crucial for preventing these skin injuries in children, though more research is needed.

Area of Science:

  • Pediatric acute care
  • Skin integrity
  • Hospital-acquired conditions

Background:

  • Limited data exists on pressure ulcer incidence and prevalence in pediatric hospitals.
  • Current prevention guidelines are adapted from adult care and lack pediatric-specific evidence.
  • Identification of at-risk pediatric patients is insufficient.

Purpose of the Study:

  • To highlight the growing priority of pressure ulcer awareness and prevention in pediatric acute care.
  • To underscore the financial implications of hospital-acquired pressure ulcers, termed 'never events' by CMS.
  • To emphasize the need for evidence-based guidelines tailored to children.

Main Methods:

  • Review of current literature and guidelines on pediatric pressure ulcers.
  • Analysis of hospital policies and reimbursement changes related to pressure ulcers.
  • Identification of knowledge gaps in pediatric pressure ulcer risk factors and prevention.

Main Results:

  • Pressure ulcers (stage III or higher) are recognized as 'never events' by the Centers for Medicare and Medicaid Services.
  • Facilities are no longer reimbursed for certain hospital-acquired conditions, including advanced-stage pressure ulcers.
  • There is a recognized need for improved awareness and prevention strategies in pediatric settings.

Conclusions:

  • Pediatric pressure ulcers are a significant and largely preventable problem.
  • Enhanced awareness and accurate patient assessment are key to prevention.
  • Further research is required to define specific risk factors and effective interventions for pediatric pressure ulcers.
Abstract

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...